Skip to content

The effects of melatonin on anxiety and pain scores of patients, intraocular pressure and operating conditions during cataract surgery under topical anesthesia

The effects of melatonin on anxiety and pain scores of patients, intraocular pressure and operating conditions during cataract surgery under topical anesthesia

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201102223051N3
Enrollment
60
Registered
2011-04-13
Start date
2009-09-17
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anxiety. Complications of medical and surgical care

Interventions

Intervention 1: sublingual melatonin 3 mg 60 minutes before surgery. Intervention 2: sublingual placebo tablet 60 minutes before surgery.
Prevention
sublingual melatonin 3 mg 60 minutes before surgery
sublingual placebo tablet 60 minutes before surgery

Sponsors

vice-chancellor for research of Qazvin university of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age 25–80 years, scheduled for elective cataract surgery with intraocular lens implantation using phacoemulsification under topical anesthesia with an ASA physical status classification I–III. Exclusion criteria: patients with sleep disorders, autoimmune disease, diabetes, depressive disorder or expected compliance problems (known psychiatric disease), epilepsy, leukemia, insufficient pupillary dilation, nystagmus, deafness, allergy to the study drugs, ongoing treatment with hypnotics or psychotropic drugs (including opioids) within a week of admission, daily analgesic treatment, ß blockers, Coumadin derivates and those who could not tolerate Shioetz tonometer during IOP measurement.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Anxiety. Timepoint: before premedication (T1), sixty minutes after premedication, on arrival in the operating room (T2), during the operation period (T3) and postoperatively. Method of measurement: VAS (verbal anxiety score).;Intraocular pressure. Timepoint: before premedication (T1), and postoperatively. Method of measurement: Shioetz tonometer.;Pain. Timepoint: before premedication (T1), 60 minutes after premedication, on arrival to the OR (T2), five minutes after the start of surgery (T3), and postoperatively before discharging the patient from the recovery room (T4). Method of measurement: Verbal pain score.

Secondary

MeasureTime frame
Arterial blood pressure. Timepoint: before premedication (T1), sixty minutes after premedication, on arrival in the operating room (T2), during the operation period (T3) and postoperatively before discharging the patient from the recovery room (T4). Method of measurement: noninvasive measurement of blood pressure.;Heart rate. Timepoint: before premedication (T1), sixty minutes after premedication, on arrival in the operating room (T2), during the operation period (T3) and postoperatively before discharging the patient from the recovery room (T4). Method of measurement: electrocardiogram.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Marzieh Beigom Khezri

Qazvin university of medical sciences and health services

mkhezri@qums.ac.ir+98 28 1222 2452

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026